Iovance Biotherapeutics Inc at JMP Securities Life Sciences Conference Transcript
So it's my pleasure to welcome Iovance Biotherapeutics. Iovance is one of our favorite cell therapy names. They're quite unique in that they're going after solid tumors. Here to tell us, obviously, a little bit about the company before we sit back and chat a little bit more in details, it's Howard Johnson, Chief Business Officer. Howard?
Thank you, Ren. Thank you for inviting us, for hosting this conference. You and your JMP colleagues. We really appreciate being here. It's great to see everybody in person, of course. And my role here is to just update you briefly on Iovance and then Ren and I will sit down and discuss some of the latest data.
I will be making forward-looking statements this afternoon, so please review the disclaimer and appreciate what it says. So just Iovance, by the numbers, to start with, just to orient you to our company. We're focused on developing therapies,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
